Nandan Padmanabha, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transdifferentiation | 1 | 2024 | 186 | 0.850 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 1512 | 0.450 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1437 | 0.450 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 497 | 0.410 |
Why?
|
| Vaccination | 1 | 2019 | 3437 | 0.270 |
Why?
|
| Carcinoma, Ductal | 1 | 2016 | 97 | 0.250 |
Why?
|
| Students, Medical | 1 | 2019 | 1964 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3231 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 4055 | 0.230 |
Why?
|
| Dioxygenases | 1 | 2023 | 353 | 0.180 |
Why?
|
| Myeloproliferative Disorders | 1 | 2023 | 616 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1424 | 0.120 |
Why?
|
| India | 1 | 2019 | 2334 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5442 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 3626 | 0.070 |
Why?
|
| Education, Medical | 1 | 2019 | 1742 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 1640 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 2043 | 0.070 |
Why?
|
| Vitamin D | 1 | 2017 | 3311 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 355 | 0.050 |
Why?
|
| Sodium Glutamate | 1 | 2017 | 22 | 0.040 |
Why?
|
| Female | 4 | 2024 | 397187 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 13091 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22371 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 223487 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1890 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 60066 | 0.020 |
Why?
|
| Humans | 4 | 2024 | 768171 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 89169 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 223646 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4034 | 0.020 |
Why?
|
| Vitamins | 1 | 2017 | 1638 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7876 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 9617 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10763 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 30009 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23782 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 13053 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30237 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18349 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 81760 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 171502 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 65379 | 0.010 |
Why?
|
| Male | 1 | 2016 | 364731 | 0.000 |
Why?
|
| Animals | 1 | 2017 | 169285 | 0.000 |
Why?
|